Amicus Therapeutics Inc
FOLD6.755USD
+0.435+6.88%
交易中 （美东）报价延迟15分钟
2.08B总市值
亏损市盈率 TTM
关于 Amicus Therapeutics Inc 公司
Amicus Therapeutics, Inc. 是一家生物技术公司，专注于发现、开发和提供治疗罕见疾病的新型药物。其上市的两种疗法是 Galafold，这是第一种针对具有易受治疗基因变异的法布里病患者的口服单药疗法，以及 Pombiliti + Opfolda，这是一种新型疗法，旨在提高活性酶进入关键疾病相关组织的吸收，适用于患有晚发型庞贝病的成年人。作为一种口服单药疗法，Galafold 旨在结合并稳定内源性 α-半乳糖苷酶 A (alpha-Gal A) 酶，适用于那些在良好实验室规范 (GLP) 细胞易受治疗性测定中被确定为易受治疗的基因变异的患者。Pombiliti + Opfolda 由独特设计的 rhGAA 酶 cipaglucosidase alfa-atga 组成，具有优化的碳水化合物结构以增强溶酶体的吸收，与作为酶稳定剂的 miglustat 联合使用。
公司简介
公司代码FOLD
公司名称Amicus Therapeutics Inc
上市日期May 31, 2007
CEOMr. Bradley Lewis Campbell
员工数量499
证券类型Ordinary Share
年结日May 31
公司地址47 Hulfish Street
城市PRINCETON
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编08542
电话16096622000
网址https://www.amicusrx.com/
公司代码FOLD
上市日期May 31, 2007
CEOMr. Bradley Lewis Campbell
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Bradley Lewis Campbell
Mr. Bradley Lewis Campbell
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
615.74K
-14.67%
Ms. Ellen S. Rosenberg, J.D.
Ms. Ellen S. Rosenberg, J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
263.90K
-16.12%
Mr. Glenn P. Sblendorio
Mr. Glenn P. Sblendorio
Independent Director
Independent Director
142.56K
+16.71%
Mr. Burke W. Whitman
Mr. Burke W. Whitman
Independent Director
Independent Director
118.60K
+20.79%
Mr. Michael G. (Mike) Raab
Mr. Michael G. (Mike) Raab
Independent Chairman of the Board
Independent Chairman of the Board
115.86K
+21.39%
Mr. Craig A. Wheeler
Mr. Craig A. Wheeler
Independent Director
Independent Director
84.63K
+31.79%
Dr. Adm. Eiry Wyn Roberts, M.D.
Dr. Adm. Eiry Wyn Roberts, M.D.
Independent Director
Independent Director
76.28K
+36.54%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
58.62K
+53.43%
Ms. Margaret G. (Margie) Mcglynn
Ms. Margaret G. (Margie) Mcglynn
Independent Director
Independent Director
51.41K
+65.85%
Mr. David M. Clark
Mr. David M. Clark
Chief People Officer
Chief People Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Bradley Lewis Campbell
Mr. Bradley Lewis Campbell
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
615.74K
-14.67%
Ms. Ellen S. Rosenberg, J.D.
Ms. Ellen S. Rosenberg, J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
263.90K
-16.12%
Mr. Glenn P. Sblendorio
Mr. Glenn P. Sblendorio
Independent Director
Independent Director
142.56K
+16.71%
Mr. Burke W. Whitman
Mr. Burke W. Whitman
Independent Director
Independent Director
118.60K
+20.79%
Mr. Michael G. (Mike) Raab
Mr. Michael G. (Mike) Raab
Independent Chairman of the Board
Independent Chairman of the Board
115.86K
+21.39%
Mr. Craig A. Wheeler
Mr. Craig A. Wheeler
Independent Director
Independent Director
84.63K
+31.79%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
Ex U.S
75.26M
60.09%
U.S
49.99M
39.91%
业务
地区
暂无数据
股东统计
更新时间: 7月12日 周六
更新时间: 7月12日 周六
持股股东
股东类型
持股股东
持股股东
占比
Wellington Management Company, LLP
9.47%
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
7.44%
Perceptive Advisors LLC
6.96%
Avoro Capital Advisors LLC
6.65%
Other
60.07%
持股股东
持股股东
占比
Wellington Management Company, LLP
9.47%
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
7.44%
Perceptive Advisors LLC
6.96%
Avoro Capital Advisors LLC
6.65%
Other
60.07%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
42.68%
Investment Advisor
33.18%
Hedge Fund
14.01%
Private Equity
7.71%
Research Firm
2.46%
Venture Capital
1.33%
Sovereign Wealth Fund
1.00%
Individual Investor
0.73%
Pension Fund
0.51%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
567
320.58M
104.11%
-8.58M
2025Q1
580
319.34M
103.72%
-10.57M
2024Q4
567
310.09M
100.94%
-22.03M
2024Q3
561
314.37M
105.97%
-28.88M
2024Q2
548
321.61M
108.47%
-24.67M
2024Q1
539
326.71M
110.33%
-17.16M
2023Q4
531
325.44M
110.85%
+1.80M
2023Q3
528
306.18M
105.38%
-26.39M
2023Q2
525
315.35M
109.92%
-11.37M
2023Q1
540
305.58M
107.88%
-22.44M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Wellington Management Company, LLP
29.20M
9.48%
+738.62K
+2.60%
Mar 31, 2025
The Vanguard Group, Inc.
29.00M
9.42%
-208.34K
-0.71%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
22.92M
7.44%
-218.69K
-0.95%
Mar 31, 2025
Perceptive Advisors LLC
21.46M
6.97%
-2.78M
-11.47%
Mar 31, 2025
Avoro Capital Advisors LLC
20.50M
6.66%
-2.67M
-11.54%
Mar 31, 2025
William Blair Investment Management, LLC
14.78M
4.8%
-819.05K
-5.25%
Mar 31, 2025
Redmile Group, LLC
9.53M
3.1%
+2.48M
+35.14%
Mar 31, 2025
State Street Global Advisors (US)
9.52M
3.09%
-842.21K
-8.13%
Mar 31, 2025
Citadel Advisors LLC
7.84M
2.55%
-400.41K
-4.86%
Mar 31, 2025
Palo Alto Investors LP
7.35M
2.39%
-317.48K
-4.14%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco Biotechnology & Genome ETF
2.44%
Virtus LifeSci Biotech Products ETF
1.79%
ALPS Medical Breakthroughs ETF
1.19%
Global X Guru Index ETF
1.08%
WisdomTree BioRevolution Fund
1.06%
SPDR S&P Biotech ETF
0.6%
First Trust Innovation Leaders ETF
0.45%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Direxion Daily S&P Biotech Bull 3X Shares
0.34%
JPMorgan Fundamental Data Science Small Core ETF
0.3%
查看更多
Invesco Biotechnology & Genome ETF
占比2.44%
Virtus LifeSci Biotech Products ETF
占比1.79%
ALPS Medical Breakthroughs ETF
占比1.19%
Global X Guru Index ETF
占比1.08%
WisdomTree BioRevolution Fund
占比1.06%
SPDR S&P Biotech ETF
占比0.6%
First Trust Innovation Leaders ETF
占比0.45%
Invesco NASDAQ Future Gen 200 ETF
占比0.43%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.34%
JPMorgan Fundamental Data Science Small Core ETF
占比0.3%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
